Cisatracurium Besylate
- Product NDC
- 0143-9396
- 11-digit product format
- 001439396
- Labeler code
- 0143
- Product ID
- 0143-9396_6c1a13e7-546c-4b06-8217-73f2c4b7ed57
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cisatracurium Besylate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Application
- ANDA203078
- Marketing category
- ANDA
- Marketing start
- 2023-05-31
- Substance
- CISATRACURIUM BESYLATE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cisatracurium Besylate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CISATRACURIUM BESYLATE | 2 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 80YS8O1MBS |
| Rxcui | 199212, 1730194 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0143-9396-01 | Cisatracurium Besylate | 1 in 1 CARTON | INJECTION | 1 | | 4 |
| 0143-9396-01 | Cisatracurium Besylate | 5 mL in 1 VIAL | INJECTION | 5 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0143-9396 | CISATRACURIUM BESYLATE INJECTION [HIKMA PHARMACEUTICALS USA INC.] | 4 | Current NDC, 2 package rows | 20250516_c5a63679-0c94-4e9d-9ac0-8ee3023bd9a6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0143-9396-01 | 00143939601 | 1 VIAL in 1 CARTON (0143-9396-01) / 5 mL in 1 VIAL | 1 vial | 2023-05-31 | No | No | Current |